JP2024543134A5 - - Google Patents
Info
- Publication number
- JP2024543134A5 JP2024543134A5 JP2024531051A JP2024531051A JP2024543134A5 JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5 JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- monovariate
- immunoglobulin
- modified immunoglobulin
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111429892.3 | 2021-11-29 | ||
| CN202111429892 | 2021-11-29 | ||
| PCT/CN2022/134923 WO2023093899A1 (zh) | 2021-11-29 | 2022-11-29 | 经修饰的蛋白或多肽 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543134A JP2024543134A (ja) | 2024-11-19 |
| JP2024543134A5 true JP2024543134A5 (https=) | 2026-03-27 |
Family
ID=86538884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531051A Pending JP2024543134A (ja) | 2021-11-29 | 2022-11-29 | 修飾されたタンパク質又はポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250026842A1 (https=) |
| EP (1) | EP4435002A4 (https=) |
| JP (1) | JP2024543134A (https=) |
| CN (1) | CN118339179A (https=) |
| TW (1) | TW202330596A (https=) |
| WO (1) | WO2023093899A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024114676A1 (zh) | 2022-11-29 | 2024-06-06 | 江苏恒瑞医药股份有限公司 | Cldn18.2/4-1bb结合蛋白及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| SG10201805064SA (en) * | 2011-06-23 | 2018-07-30 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| RS55775B2 (sr) * | 2011-06-23 | 2022-10-31 | Ablynx Nv | Tehnike za predviđanje, otkrivanje i smanjenje nespecifične proteinske interferencije u testovima koji uključuju pojedinačne varijabilne domene imunoglobulina |
| PE20141522A1 (es) | 2011-08-17 | 2014-11-17 | Glaxo Group Ltd | Proteinas y peptidos modificados |
| AU2013258834B2 (en) * | 2012-05-10 | 2017-09-07 | Zymeworks Bc Inc. | Heteromultimer constructs of immunoglobulin heavy chains with mutations in the Fc domain |
| WO2014111550A1 (en) * | 2013-01-17 | 2014-07-24 | Glaxosmithkline Intellectual Property Development Limited | Modified anti-serum albumin binding proteins |
| EP4707303A2 (en) * | 2014-05-16 | 2026-03-11 | Ablynx NV | Improved immunoglobulin variable domains |
| JP7001474B2 (ja) * | 2015-01-21 | 2022-01-19 | インヒブルクス，インコーポレイティド | 非免疫原性単一ドメイン抗体 |
| NO2768984T3 (https=) * | 2015-11-12 | 2018-06-09 | ||
| CN113621065B (zh) * | 2021-08-30 | 2023-08-01 | 武汉海沙百得生物技术有限公司 | 靶向4-1bb的全人源抗体及其制备方法和应用 |
-
2022
- 2022-11-29 US US18/713,577 patent/US20250026842A1/en active Pending
- 2022-11-29 TW TW111145700A patent/TW202330596A/zh unknown
- 2022-11-29 JP JP2024531051A patent/JP2024543134A/ja active Pending
- 2022-11-29 EP EP22897980.3A patent/EP4435002A4/en active Pending
- 2022-11-29 CN CN202280075005.3A patent/CN118339179A/zh active Pending
- 2022-11-29 WO PCT/CN2022/134923 patent/WO2023093899A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503455A5 (https=) | ||
| JP2021191763A5 (https=) | ||
| US20250034248A1 (en) | Monoclonal antibodies against human tim-3 | |
| JP2021073279A (ja) | Ｉｇｆ−１ｒ抗体および癌処置のためのアドレッシングビヒクルとしてのその使用 | |
| JP2020525032A5 (https=) | ||
| CA3005085C (en) | IMPROVED TNF BINDERS | |
| JP2018522888A5 (https=) | ||
| JP2019520797A5 (https=) | ||
| JP2019533719A5 (https=) | ||
| JP2017529067A (ja) | Ｃｄ３結合ドメイン | |
| JP2016529882A5 (https=) | ||
| JP2019502656A (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| JP2019501883A5 (https=) | ||
| JP2018526981A5 (https=) | ||
| JP2023516280A5 (https=) | ||
| JP2021520832A5 (https=) | ||
| JP2018510636A5 (https=) | ||
| JP2013500703A5 (https=) | ||
| JP2021512159A5 (https=) | ||
| JP2023543493A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2020502233A5 (https=) | ||
| WO2022238550A1 (en) | Pan-specific corona virus binders | |
| JP2023522212A5 (https=) | ||
| JP2022540610A5 (https=) |